Dr Alan Goddard

Professor of Biotechnology and Head of Biosciences Aston University

  • Birmingham

Prof. Goddard has a particular interest in applying fundamental findings about the cell membrane and its constituent lipids and proteins.

Contact

Aston University

View more experts managed by Aston University

Spotlight

3 min

New podcast: Aston University research institute team discuss membrane separations and chocolate boxes

Aston Institute of Membrane Excellence’s Dr Matt Derry was joined by Dr Alan Goddard and France-based research partner Dr Mona Semsarilar They discussed the BIOMEM project, which received £3m from the European Innovation Council (EIC) Pathfinder programme BIOMEM will develop a bioinspired membrane to selectively extract compounds from water (like finding a favourite chocolate in a box) In the latest Aston Institute for Membrane Excellence (AIME) podcast, three researchers discuss the international BIOmimetic selective extraction MEMbranes (BIOMEM) project and how it will feed into AIME’s work. BIOMEM will develop a bioinspired membrane technology to selectively extract compounds from water, using 50-75% less energy than current state-of-the-art nanofiltration technologies. The membranes will work at low pressures and at low concentration of the target molecule. Podcast host Dr Matt Derry was joined by fellow AIME researcher Dr Alan Goddard and Dr Mona Semsarilar from the French National Centre for Scientific Research (Centre national de la recherche scientifique (CNRS)). The BIOMEM project, which involves collaborators from across Europe, is being led by Dr Torsten Bak from Danish company Aquaporin, with Dr Goddard the research lead at Aston University. Dr Goddard explained: “You might want to work on a biotechnology process where you've made a high value chemical that you want to extract from a complex mix, and at the moment you might have to concentrate your solution up, and you might have to do six or seven filtration steps. We want a filter that does it in a single step using a biological transporter. “And if you can do that in a single step in a platform technology, you'll make all these brilliant biotech processes more commercialisable, reduce your reliance on petrochemicals, and to maybe oversell what we can do, save the planet.” Dr Derry likened it to a quick way to find your favourite chocolate in a box at Christmas. Rather than scrabbling through, taking out one type at a time until you find your favourite, the process can immediately separate it out with minimal effort. Aquaporin has developed a membrane that can selectively transport only water molecules to quickly purify water, which is already in use across the world, and even out of this world, for space missions. Dr Bak and the team will bring their membrane expertise to the project. The team at CNRS, led by polymer scientist Dr Semsarilar, is working on a number of projects for BIOMEM, including developing a type of crystalline material called trianglamine, which they can modify through chemical processes to be hydrophobic or hydrophilic to make things like water channels or adsorption sites, which can be embedded in polymer network for purification processes. Other researchers at AIME, including Dr Derry and Professor Paul Topham, will work on the ‘glue’ to stick the biological elements of the membranes to the non-biological polymer matrix. BIOMEM will also benefit from the input of partners across Europe including dsm-firmenich, University of Copenhagen and Tampere University. The podcast was recorded just after the project kick-off meeting with all the project partners, which was held at Aston University in May 2024. Listen to the full podcast on the Aston Originals YouTube page.

Dr Alan GoddardDr Matthew DerryPaul Topham

5 min

Aston University receives £10m from Research England to establish the Aston Institute for Membrane Excellence

Image shows how tiny water channels control how water enters and exits cells through their membranes The Aston Institute for Membrane Excellence (AIME) will be set up with a £10m grant from Research England AIME will be led by Professor Roslyn Bill from Biosciences and Professor Paul Topham from Chemical Engineering and Applied Chemistry The globally unique institute will use biomimetic polymer membranes for applications such as water purification and drug development Aston University will establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes, after receiving a major grant of £10m from Research England. AIME will be led by Professor Roslyn Bill, from the School of Biosciences, with co-lead Professor Paul Topham from the department of Chemical Engineering and Applied Chemistry (CEAC). Membranes, both biological and synthetic, are hugely important in many sectors. For example, the world’s top ten selling human medicines all target proteins in biological membranes, while synthetic polymer membranes are used in the US$100bn/year water purification industry. The team behind AIME believes that the full potential of membranes will only be realised by an interdisciplinary group spanning biology, physics and chemistry that can investigate membranes holistically. Professor Bill, a European Research Council (ERC) Advanced grantee leads Aston Membrane Proteins and Lipids (AMPL) research centre of excellence that studies the structure and function of membrane proteins and associated lipids. Professor Topham leads Aston Polymer Research Group (APRG), which investigates the nanoscale behaviour of block copolymers (a type of polymer with a structure made of more than one type of polymer molecule) and polymer technologies for membranes. AMPL and APRG have already begun collaborative research and AIME will bring together the complementary expertise of both research clusters into one institute. AIME will initially comprise the eight researchers from AMPL and APRG. Alongside the co-leads Professor Bill and Professor Topham, will be Dr Alan Goddard, Professor Andrew Devitt, Professor Corinne Spickett, Dr Alice Rothnie, Dr Matt Derry and Dr Alfred Fernandez. It plans to recruit three further academics, six tenure-track research fellows, three postdoctoral research assistants (PDRAs), six PhD students, a research technician and a business development manager. Importantly, AIME will work with many existing Aston University colleagues to build a comprehensive research community focused on all aspects of membrane science. The new AIME team will focus on the development of bioinspired, highly selective polymer structures for applications in water purification and waste remediation, nanoparticles loaded with therapeutic molecules to treat disorders ranging from chronic wounds to neurological injuries, and the purification of individual membrane proteins with polymers to study them as drug targets. The vision is for AIME to become a ‘one-stop shop’ for interdisciplinary, translational membrane research through its facilities access and expertise, ideally located in the heart of the country. Professor Bill said: “The creation of AIME is ground-breaking. Together with Aston’s investment, E3 funding will deliver a step-change in scale and the rate at which we can grow capacity. We will address intractable scientific challenges in health, disease, and biotechnology, combining our world-class expertise in polymer chemistry and membrane biology to study membranes holistically. The excellence of our science, alongside recent growth in collaborative successes means we have a unique opportunity to deliver AIME’s ambitious and inclusive vision.” Professor Topham said: “We are really excited by this fantastic opportunity to work more closely with our expert colleagues in Biosciences to create advanced technology to address real world problems. From our side, we are interested in molecular engineering, where we control the molecular structure of new materials to manipulate their properties to do the things that we want! Moreover, we are passionate about a fully sustainable future for our planet, and this investment will enable us to develop technological solutions in a sustainable or ‘green’ way.” Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University, says: “Our new Aston Institute for Membrane Excellence (AIME) will be a regional, national, and international research leader in membrane science, driving game-changing research and innovation that will produce a pipeline of high-quality research outcomes leading to socioeconomic impact, develop future global research leaders, create advanced tech spinout companies and high value-added jobs for Birmingham and the West Midlands region. Its establishment aligns perfectly with our 2030 strategy that positions Aston University as a leading university of science, technology and enterprise.” Steven Heales, Policy Manager (Innovation) at the West Midlands Combined Authority, said: “WMCA is delighted to see Research England back the Aston Institute for Membrane Excellence. This will enable Aston University’s excellent academics and research community to work closely with businesses to make advances in membrane technology and applications. “In 2023 the West Midlands Combined Authority agreed a Deeper Devolution Trailblazer Deal with Government, which included a new strategic innovation partnership with Government. Projects like AIME are exactly the kind of impact we expect this new partnership to generate, so watch this space.” Lisa Smith, chief executive of Midlands Mindforge, the patient capital investment company formed by eight Midlands research-intensive universities including Aston University, said: “This grant is an important vote of confidence in the Midlands scientific R&D ecosystem. AIME will play an important role in the future research of pioneering breakthroughs in membrane science and enable the world-leading research team at Aston University to develop solutions to real world problems. We look forward to closely working with the Institute and nurturing best-in-field research being undertaken at Aston out of the lab and into the wider society so it can make a positive impact”. Rob Valentine, regional director of Bruntwood SciTech, the UK’s leading developer of city-wide innovation ecosystems and specialist environments and a strategic partner in Birmingham Innovation Quarter, said: "As a proud supporter of the Aston Institute for Membrane Excellence (AIME), I am thrilled at the launch of this groundbreaking initiative. AIME exemplifies Aston University's commitment to advancing cutting-edge interdisciplinary research and further raises the profile of the region’s exemplary research capabilities and sector specialisms. AIME's vision of becoming a 'one-stop shop' for translational membrane research, strategically located at the heart of the country, aligns perfectly with our strategy at Bruntwood SciTech. We are committed to working with partners, including Aston University, to develop a globally significant innovation district at the heart of the UK where the brightest minds and most inspiring spaces will foster tomorrow’s innovation.” Membrane research at Aston University has also recently received two other grants. In November 2023, Professor Bill received £196,648 from the Biotechnology and Biological Sciences Research Council’s Pioneer Awards Scheme to understand how tiny membrane water channels in brain cells keep brains healthy. In December 2023, a team led by AIME team-member Dr Derry received £165,999 from the Engineering and Physical Sciences Research Council to develop biomimetic membranes for water purification. For more information about AIME, visit the webpage.

Dr Alan GoddardRoslyn BillPaul TophamDr Matthew DerryAndrew Devitt

Media

Social

Biography

Prof. Goddard joined Aston in October 2016 as a Lecturer in Biochemistry, having spent the previous four years as a Senior Lecturer in Biochemistry at the University of Lincoln. Prior to that, he spent nearly seven years as a postdoctoral researcher at the University of Oxford. Dr. Goddard completed both his BSc and PhD at the University of Warwick.

Goddard's research interests focus around membrane proteins and the lipid membranes in which they reside. He has experience of working with a range of membrane protein systems including receptors such as GPCRs, transporters and biogenesis systems. He uses model lipid membranes to study proteins in their native environments and also to probe the effects of various compounds on the integrity of the membrane itself. For example, he has investigated the lipid-specific effects of antimicrobials and solvent on biological membranes and has a substantial interest in biomimetic membranes. They has has collaborations with >25 industrial partners. He is the Training and Industry Lead for the Aston Institute for Membrane Excellence (AIME) and the Chief Scientific Officer of MEMetic.

Areas of Expertise

Biological Membranes
Membrane Proteins
Lipids
Lipid Nanoparticles
Biotechnology
Microbiology

Education

University of Lincoln

PGCE HE

2016

University of Warwick

PhD

Biological Sciences

2006

University of Warwick

BSc (Hons)

Biological Sciences with Molecular Genetics

2002

Affiliations

  • Member of Biochemical Society (Local Ambassador and Member of Training Theme Panel)
  • Member of Microbiology Society
  • Member of British Biophysical Society
  • Senior Fellow of Higher Education Academy

Media Appearances

Aston Institute for Membrane Excellence wins £13.2m of UK government and co-funding for water treatment technology

Aston University  

2025-11-02

Professor Goddard and Dr Derry said:

“MEMetic represents the culmination of years of planning a significant, challenging, interdisciplinary research programme which promises massive real-world benefits. This RVC award will allow us to leverage our fundamental science to create bespoke bioinspired filtration membranes for a range of industries. Such research really requires long term funding which is set up to take research to an applied setting and the research venture we envisage perfectly matches our philanthropic aims for water treatment for all.”

View More

Alan Goddard visits

University of Lincoln - Centre for Computational Physics  online

2018-01-24

On the 24th of January 2018 Dr Alan Goddard from Aston University visited our School to discuss future collaborations and to deliver a seminar on cell membranes in biotechnology. The talk was well attended, by members of the School of Maths & Physics and the School of Life Sciences.

View More

Research Grants

Optimal cell factories for membrane protein production

UKRI Engineering Biology Mission Award Expand and Extend

January 2026-April 2027

Engineering of Extracellular Vesicles for Oral Delivery of Nucleic Acid Therapies

UKRI Engineering Biology Mission Award Expand and Extend

January 2026-April 2027

Beamtime for SAXS and SEC-SAXS

Diamond SAXS BAG

July 2025 (renewed December 2025)

Show All +

Articles

Engineered extracellular vesicles demonstrate altered endocytosis and biodistribution and have superior oral siRNA delivery efficiency compared to lipid nanoparticles

International Journal of Pharmaceutics: X

2025

Oral administration of RNA therapeutics remains a major unsolved challenge due to currently insurmountable biological barriers. Extracellular vesicles (EVs) are natural carriers capable of traversing the intestinal barrier, but inefficient RNA loading into EVs in general severely limits the application of EVs for RNA delivery. Here, we utilize a microfluidic engineering platform to generate milk-derived EV-lipid nanoparticle (EV-LNP) hybrids for oral delivery of RNA. The process produced uniform nanoparticles (133 nm, polydispersity index 0.19) with >45 % dual-positive fusion efficiency, significantly outperforming freeze–thaw hybridization. Compared to conventional LNPs, EV-LNP hybrids exhibited lower cytotoxicity, altered epithelial uptake pathways, and markedly improved intestinal epithelial transport.

View more

Membrane manipulation by free fatty acids improves microbial plant polyphenol synthesis

Nature Communications

2023

Microbial synthesis of nutraceutically and pharmaceutically interesting plant polyphenols represents a more environmentally friendly alternative to chemical synthesis or plant extraction. However, most polyphenols are cytotoxic for microorganisms as they are believed to negatively affect cell integrity and transport processes. To increase the production performance of engineered cell factories, strategies have to be developed to mitigate these detrimental effects. Here, we examine the accumulation of the stilbenoid resveratrol in the cell membrane and cell wall during its production using Corynebacterium glutamicum and uncover the membrane rigidifying effect of this stilbenoid experimentally and with molecular dynamics simulations. A screen of free fatty acid supplements identifies palmitelaidic acid and linoleic acid as suitable additives to attenuate resveratrol’s cytotoxic effects resulting in a three-fold higher product titer. This cost-effective approach to counteract membrane-damaging effects of product accumulation is transferable to the microbial production of other polyphenols and may represent an engineering target for other membrane-active bioproducts.

View more

Identification of membrane engineering targets for increased butanol tolerance in Clostridium saccharoperbutylacetonicum

Biochimica et Biophysica Acta (BBA) - Biomembranes

2023

There is a growing interest in the use of microbial cell factories to produce butanol, an industrial solvent and platform chemical. Biobutanol can also be used as a biofuel and represents a cleaner and more sustainable alternative to the use of conventional fossil fuels. Solventogenic Clostridia are the most popular microorganisms used due to the native expression of butanol synthesis pathways. A major drawback to the wide scale implementation and development of these technologies is the toxicity of butanol. Various membrane properties and related functions are perturbed by the interaction of butanol with the cell membrane, causing lower yields and higher purification costs. This is ultimately why the technology remains underemployed. This study aimed to develop a deeper understanding of butanol toxicity at the membrane to determine future targets for membrane engineering.

View more

Show All +